Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D000959:Antihypertensive Agents; D001681:Biological Assay; D001920:Bradykinin / Q000494:pharmacology*; D004285:Dogs; D011464:Epoprostenol / Q000097:blood* / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011453:Prostaglandins / Q000097:blood*; D012504:Saralasin / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D011453:Prostaglandins; D010643:Phenoxybenzamine; D011433:Propranolol; D011464:Epoprostenol; D012504:Saralasin; D001920:Bradykinin